Controversy regarding Human embryonic Stem Cell (hESC) research is evident in the medical and scientific community, legislative, judicial, and executive branches of the government, private companies, religious affiliations, special interest groups, and among the general American public . Stem cells are derived from adult stem cell resources, which are termed "non-embryonic" or from the cells of immature blastocysts termed "embryonic" stem cells 1 . Non-embryonic cells do not have the ability to differentiate into other specialized tissues, whereas embryonic cells are capable of differentiating into almost any type of tissue. 2 hESC research, which is the focus of this paper, includes the direct creation and "therapeutic cloning" of human embryos, known as somatic cell nuclear transfer (SCNT) 3 during the blastocyst-stage of development, 4 the use of surplus embryos from in vitro fertilization 5 , and from tissue derived from extracted embryos through abortion. The purpose of hESC research is threefold: (1) to advance science and medicine, (2) prevent disease, and (3) cure certain diseases. The most useful type of stem cell is the "pluripotent stem cell" and is derived directly from the blastocyst during the five to seven days after fertilization 6 . This limited time period for optimization of hESC research suggests a greater need for SCNT to provide embryos specific to this stage of development for optimal differentiation of tissues. Others continue to argue that "we simply do not know which type of stem cell research is the most promising". The opposition argument often refers to the unique problems related to pluripotent embryonic stem cell development, including the probability of forming certain prolific tumors due to uncontrolled cell division 7 Early 20 th century American medical controversies centered on eugenics, birth control, population control, and planned reproduction 8 . Similar reproductive themes including hESC and cloning, one century later, have erupted in American society. The majority of the American public agrees that human cloning for reproductive purposes should be banned. However, the debate regarding the use of cloned embryos for research purposes remains volatile. Religious ethicists provide arguments according to moral motivation and guidance.
Catholic religious ethicists argue against hESC research based on grounds of "murder of the embryo". Judaism presents a more complex and rich argument with exceptions allowed for in vitro fertilization embryos, tissue extracted from abortive fetuses already destined for destruction, and "therapeutic cloning" based on the embryos decreased status when outside the womb. 9 The Islamic viewpoint is not as clear with some siding with the Catholic stance on hESC research and other scholars quoting a termination date of 56 days post fertilization as the acceptable period for extraction processes. 1011 Many religious and secular opponents to hESC research fear this type of "therapeutic cloning" will be used in future generations for actual cloning of human beings. 12 An example of this perspective is reflected in the Weldon Bill, which proposed criminalization of all cloning, including "therapeutic cloning". In 1975, a federal rule was enacted that disallowed for any research to be done on in vitro fertilization products until reviewed and accepted by the Ethics Advisory Board (EAB). This appeared to be an early attempt to acknowledge the "potentiality of autonomy" of the embryo and right to respect and dignity. The rule was directed toward embryos resulting directly from in vitro fertilization and may have also been a reaction to protect abortive embryos from scientific experimentation from the 1973 Roe Vs Wade ruling. However, in 1979, the EAB gave the approval to fund embryonic research under certain circumstances. In 1980, the federal rule remained in place that required the EAB to approve all funding for hESC, however the EAB's charter expired, leaving a "defacto moratorium" on embryonic stem cell research. This problem was soon resolved when President Clinton, in 1993, reminded the public of the rights of society to advance medical treatments that would benefit society and rescinded the rule that required EAB approval and allowed for HESC research to resume.
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In 1996, the Dickey Amendment was passed with the "Department of Labor, Health, Human Services, Education, and Related Agencies Act", which again discontinued federal funding of hESC. The battle continued regarding federal funding of hESC, however, when the Dickey Amendment was interpreted narrowly to allow federal funding but only on "private hESC research lines". 18 The rule disallowing federal funds to be placed toward hESC research while private companies are able to legally advance hESC through silent policy of the government is a product of our pluralist governmental system. Religious ethics regarding "embryo dignity"
have been tested against those who hold a form of prima facie duties perspective where "exceptions, when they conflict with other duties, have greater importance in a given situation" 19 Some also argue, from a Kant duty ethicist perspective, whether embryos that have the potential for rationality, but are not, in essence, rational human beings at the blastocyst stage, be considered "rational" for purposes of protection.
In August 2001, President Bush, seemingly supporting a rights ethicist viewpoint in regards to human embryos, stated that "human embryonic stem cell research is morally wrong" and proclaimed that he would not fund any hESC research lines created after August 9, 2001.
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President Bush, however, has been criticized for inconsistency in his argument regarding hESC funding and the failure to halt any private research on hESC as well as the presidential endorsement and funding of contrary policies regarding fundamental value of adult human life in issues surrounding the Iraq War, Guantanamo Bay, the "acceptable" use of torture, and failure to provide adequate aide to Hurricane Katrina victims during his presidency. 21 Shortly after the presidential ban on hESC research, Congress considered a ban on human cloning altogether. However, this failed to materialize because of the difficulties arising from problematic terminology restricting "all cloning" which could lead to restrict even therapeutic adult cell tissue "splicing" of tissue from individuals with disease for regeneration of healthy tissue. 22 Those in favor of a cloning ban included the United Sates Conference of Catholic Bishops, The Family Research Council, and the Methodist Church. The banning of cloning has been described by religious and secular communities in terms of "negative immortality", the continual regeneration and preservation of life at all costs, as opposed to "positive immortality", the belief that extending one's own life is not as desirable as leading a good life. 23 Some bioethicists have raised distinctive concerns termed the "created-discarded" ethics of allowing for embryos "slated for destruction" to be saved for hESC, but not accepting those lines of hESC which would promote creation of more embryos than necessary solely for research purposes. Distributive justice is breeched when access to health care involving hESC research will be limited for the general public, the socioeconomically disadvantaged, and those who live in states who do not support this type of research or treatment. Distributive justice must also include the "embryonic" tissue, which calls into question the actual definition of a five to seven day old blastocyst and the moral obligation of the embryo/blastocyst at stake. Terminology has traditionally termed the cells in order from conception as blastocyst, zygote, embryo, and fetus by the scientific community. However, recent terminology changes initiated in science textbooks across the country by pro-life groups with primarily protestant and Catholic religious roots, have reflected the often debated subject by creating only one term the "embryo" to describe all stages prior to the "fetus". This provides for a legal and ethical background to support the ban on hESC research at any level of development as a "basic right" of the embryo. 30 In conclusion, hESC research is an ethical dilemma facing the United States of America. Opponents of hESC often cite the "rights" of the embryo and define the embryo at conception. Supporters of hESC research include the scientific and medical community, and private hESC research companies. From a utilitarian perspective, they also cite "rights", but refer to the rights of the adults who need advancement in medical care
and cures for current debilitating diseases and do not consider a 5-7 day old blastocyst as more than cellular mass to be used in research purposes. The unique political system of the United States has allowed for a dichotomous policy to arise, where federal funding of hESC is prohibited, but private companies and individual states are able to legally forge a path in hESC research. The prohibition of federal funds has created an abyss between states who choose to fund hESC research and those who prohibit it. It has also set the stage for yet another private corporation to advance in hESC and place profit above the American public. The embryo is the only silent member of this debate.
